Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 4Unknown 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2von Hippel-Lindau Disease 1Ulcer 1Triple Negative Breast Neoplasms 1Smoldering Multiple Myeloma 1Skin Neoplasms 1Sarcoma, Kaposi 1Neoplasms 1Multiple Myeloma 1Melanoma 1Liver Neoplasms 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangioma, Capillary 1Hemangioblastoma 1Fallopian Tube Neoplasms 1Digestive System Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1

Interventions

Ultrasonography 1Timolol 1Surgery, Computer-Assisted 1Propranolol 1Lasers, Solid-State 1Lasers, Dye 1Lasers 1Adrenergic beta-Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hemangioma, Capillary × Propranolol × Clear all
NCT06798363 2026-03-16

Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

West China Hospital

Phase 2/3 Recruiting
40 enrolled

Ulcer, Hemangioma, Capillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡